Clinical Nurse Specialist in Highland Park, IL Accepting Medicare

2 Clinical Nurse Specialist nurses found. Showing 1 - 2

Ruby G. Gubat, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 777 Park Ave W, Ep Lab, Rm 1111, Highland Park, IL 60035 Phone: 847-480-2641    Fax: 847-926-5332

Carole Sims Henn Martz, CNS Clinical Nurse Specialist - Oncology Medicare: Not Enrolled in Medicare Practice Location: 757 Park West, Highland Park Hospital, Highland Park, IL 60035 Phone: 847-926-5818    Fax: 847-480-3805

News Archive

Engineered T cells can eradicate deadly human ovarian cancer in immune-deficient mice

In a recent issue of Cancer Research, Daniel J. Powell, Jr., PhD, a research assistant professor of Pathology and Laboratory Medicine and Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania, showed for the first time that engineered human T cells can eradicate deadly human ovarian cancer in immune-deficient mice.

Early diagnosis and treatment of heart disease may lead to longer life in Duchenne and Becker muscular dystrophy patients

Cardiac disease, particularly dilated cardiomyopathy and heart failure, is the major cause of mortality in patients with muscular dystrophy and is present in most boys with Duchenne muscular dystrophy and approximately 70 percent of those with Becker muscular dystrophy. These are the two common forms of muscular dystrophy caused by defects in a gene called dystrophin.

Inserm Transfert, MedImmune collaborate to advance medical science research

MedImmune, the global biologics business of AstraZeneca, and Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research, today announced a three-year strategic collaboration to advance research across a range of therapeutic areas including oncology, respiratory, inflammation, and autoimmune diseases.

FDA, pharmaceutical industry reach agreement on user-fee plan for generics

The Food and Drug Administration would collect hundreds of millions of dollars in new fees from pharmaceutical companies to help speed up the review of generic drugs, under an agreement with the industry released by the agency on Friday.

Read more Medical News

› Verified 1 days ago